USD 98.65
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 43.07 Billion EUR | -5.11% |
2022 | 45.38 Billion EUR | 15.86% |
2021 | 39.17 Billion EUR | 4.83% |
2020 | 37.36 Billion EUR | -0.7% |
2019 | 37.63 Billion EUR | 5.48% |
2018 | 35.67 Billion EUR | -1.46% |
2017 | 36.2 Billion EUR | 4.31% |
2016 | 34.7 Billion EUR | -0.44% |
2015 | 34.86 Billion EUR | 2.2% |
2014 | 34.1 Billion EUR | 2.41% |
2013 | 33.3 Billion EUR | -7.37% |
2012 | 35.95 Billion EUR | 2.56% |
2011 | 35.05 Billion EUR | 9.44% |
2010 | 32.03 Billion EUR | 4.18% |
2009 | 30.74 Billion EUR | 6.7% |
2008 | 28.81 Billion EUR | -1.49% |
2007 | 29.25 Billion EUR | -0.8% |
2006 | 29.48 Billion EUR | 3.5% |
2005 | 28.49 Billion EUR | 89.54% |
2004 | 15.03 Billion EUR | 87.1% |
2003 | 8.03 Billion EUR | 7.77% |
2002 | 7.45 Billion EUR | 14.91% |
2001 | 6.48 Billion EUR | 8.8% |
2000 | 5.96 Billion EUR | 11.46% |
1999 | 5.35 Billion EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 14.15 Billion EUR | -33.25% |
2024 Q1 | 11.11 Billion EUR | -51.41% |
2024 Q2 | 21.2 Billion EUR | 90.76% |
2023 Q3 | 12.69 Billion EUR | 18.87% |
2023 Q4 | 22.88 Billion EUR | 80.21% |
2023 Q1 | 10.86 Billion EUR | -5.18% |
2023 FY | 43.07 Billion EUR | -5.11% |
2023 Q2 | 10.68 Billion EUR | -1.67% |
2022 Q1 | 10.05 Billion EUR | -3.48% |
2022 Q2 | 10.74 Billion EUR | 6.85% |
2022 Q3 | 13.13 Billion EUR | 22.3% |
2022 Q4 | 11.45 Billion EUR | -12.8% |
2022 FY | 45.38 Billion EUR | 15.86% |
2021 Q2 | 9.04 Billion EUR | 1.79% |
2021 Q3 | 10.82 Billion EUR | 19.72% |
2021 Q4 | 10.41 Billion EUR | -3.82% |
2021 FY | 39.17 Billion EUR | 4.83% |
2021 Q1 | 8.88 Billion EUR | -8.73% |
2020 Q1 | 9.31 Billion EUR | -7.0% |
2020 Q2 | 8.43 Billion EUR | -9.42% |
2020 Q3 | 9.87 Billion EUR | 17.08% |
2020 FY | 37.36 Billion EUR | -0.7% |
2020 Q4 | 9.73 Billion EUR | -1.45% |
2019 Q2 | 8.98 Billion EUR | 3.06% |
2019 Q1 | 8.71 Billion EUR | -6.57% |
2019 FY | 37.63 Billion EUR | 5.48% |
2019 Q4 | 10.01 Billion EUR | 0.97% |
2019 Q3 | 9.92 Billion EUR | 10.48% |
2018 Q1 | 8.12 Billion EUR | -9.52% |
2018 Q2 | 8.48 Billion EUR | 4.37% |
2018 Q3 | 9.74 Billion EUR | 14.89% |
2018 Q4 | 9.32 Billion EUR | -4.29% |
2018 FY | 35.67 Billion EUR | -1.46% |
2017 Q1 | 8.89 Billion EUR | -3.05% |
2017 Q3 | 9.39 Billion EUR | 5.15% |
2017 Q4 | 8.98 Billion EUR | -4.39% |
2017 FY | 36.2 Billion EUR | 4.31% |
2017 Q2 | 8.93 Billion EUR | 0.4% |
2016 FY | 34.7 Billion EUR | -0.44% |
2016 Q2 | 8.3 Billion EUR | 4.79% |
2016 Q1 | 7.92 Billion EUR | -10.09% |
2016 Q4 | 9.17 Billion EUR | -1.27% |
2016 Q3 | 9.29 Billion EUR | 11.88% |
2015 Q3 | 9.68 Billion EUR | 2.31% |
2015 FY | 34.86 Billion EUR | 2.2% |
2015 Q1 | 8.89 Billion EUR | -3.05% |
2015 Q4 | 8.81 Billion EUR | -8.9% |
2015 Q2 | 9.46 Billion EUR | 6.42% |
2014 Q2 | 8.14 Billion EUR | 2.79% |
2014 Q1 | 7.92 Billion EUR | -7.26% |
2014 FY | 34.1 Billion EUR | 2.41% |
2014 Q3 | 8.86 Billion EUR | 8.86% |
2014 Q4 | 9.17 Billion EUR | 3.41% |
2013 Q2 | 8.08 Billion EUR | -0.87% |
2013 Q1 | 8.15 Billion EUR | -5.84% |
2013 FY | 33.3 Billion EUR | -7.37% |
2013 Q4 | 8.54 Billion EUR | 0.32% |
2013 Q3 | 8.51 Billion EUR | 5.34% |
2012 Q4 | 8.66 Billion EUR | -6.24% |
2012 FY | 35.95 Billion EUR | 2.56% |
2012 Q1 | 8.93 Billion EUR | 0.16% |
2012 Q3 | 9.24 Billion EUR | 1.35% |
2012 Q2 | 9.11 Billion EUR | 2.01% |
2011 FY | 35.05 Billion EUR | 9.44% |
2011 Q4 | 8.92 Billion EUR | -2.71% |
2011 Q1 | 8.19 Billion EUR | 4.89% |
2011 Q2 | 8.77 Billion EUR | 7.07% |
2011 Q3 | 9.17 Billion EUR | 4.57% |
2010 Q3 | 8.25 Billion EUR | 0.83% |
2010 FY | 32.03 Billion EUR | 4.18% |
2010 Q4 | 7.81 Billion EUR | -5.44% |
2010 Q2 | 8.19 Billion EUR | 5.35% |
2010 Q1 | 7.77 Billion EUR | 0.6% |
2009 Q1 | 7.45 Billion EUR | -0.07% |
2009 FY | 30.74 Billion EUR | 6.7% |
2009 Q4 | 7.72 Billion EUR | -0.55% |
2009 Q3 | 7.77 Billion EUR | -0.32% |
2009 Q2 | 7.79 Billion EUR | 4.64% |
2008 Q1 | 7.22 Billion EUR | -11.54% |
2008 FY | 28.81 Billion EUR | -1.49% |
2008 Q4 | 7.45 Billion EUR | 4.06% |
2008 Q3 | 7.16 Billion EUR | 0.85% |
2008 Q2 | 7.1 Billion EUR | -1.62% |
2007 FY | 29.25 Billion EUR | -0.8% |
2007 Q3 | 6.96 Billion EUR | -4.92% |
2007 Q2 | 7.33 Billion EUR | 3.9% |
2007 Q1 | 7.05 Billion EUR | -4.47% |
2007 Q4 | 8.16 Billion EUR | 17.12% |
2006 Q2 | 7.44 Billion EUR | 1.69% |
2006 FY | 29.48 Billion EUR | 3.5% |
2006 Q1 | 7.32 Billion EUR | -0.32% |
2006 Q4 | 7.38 Billion EUR | 0.42% |
2006 Q3 | 7.35 Billion EUR | -1.19% |
2005 Q2 | 6.81 Billion EUR | 2.33% |
2005 Q4 | 7.34 Billion EUR | -2.21% |
2005 Q3 | 7.5 Billion EUR | 10.24% |
2005 Q1 | 6.65 Billion EUR | 25.0% |
2005 FY | 28.49 Billion EUR | 89.54% |
2004 Q1 | 2.22 Billion EUR | 25.71% |
2004 FY | 15.03 Billion EUR | 87.1% |
2004 Q3 | 5.33 Billion EUR | 139.5% |
2004 Q2 | 2.22 Billion EUR | 0.01% |
2004 Q4 | 5.32 Billion EUR | -0.17% |
2003 Q1 | 1.94 Billion EUR | 3.09% |
2003 Q2 | 1.94 Billion EUR | 0.1% |
2003 Q3 | 2.41 Billion EUR | 24.12% |
2003 Q4 | 1.77 Billion EUR | -26.71% |
2003 FY | 8.03 Billion EUR | 7.77% |
2002 Q3 | 1.87 Billion EUR | 1.87% |
2002 Q2 | 1.83 Billion EUR | 0.0% |
2002 FY | 7.45 Billion EUR | 14.91% |
2002 Q4 | 1.88 Billion EUR | 0.86% |
2001 FY | 6.48 Billion EUR | 8.8% |
2000 FY | 5.96 Billion EUR | 11.46% |
1999 FY | 5.35 Billion EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AstraZeneca PLC | 46.91 Billion USD | 8.195% |
Bristol-Myers Squibb Company PFD CONV 2 | 45 Billion USD | 4.302% |
CSPC Pharmaceutical Group Limited | 31.45 Billion USD | -36.947% |
Clarus Therapeutics Holdings, Inc. | 13.95 Million USD | -308490.671% |
Novartis AG | 46.66 Billion USD | 7.694% |
PT Kalbe Farma Tbk. | 1.97 Billion USD | -2076.139% |